Effect of glucagon, dibutyryl adenosine 3′,5′-cyclic monophosphate and phosphodiesterase inhibitors on rat liver phosphorylase activity and adenosine 3′,5′-cyclic monophosphate levels
- 1 August 1974
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 23 (15) , 2139-2146
- https://doi.org/10.1016/0006-2952(74)90579-6
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- THE COLORIMETRIC DETERMINATION OF PHOSPHORUSPublished by Elsevier ,2021
- 1-ethyl-4-(isopropylidenehydrazino)-1H-pyrazolo-(3,4-b)-pyridine-5-carboxylic acid, ethyl ester, hydrochloride (SQ 20009)—a potent new inhibitor of cyclic 3′,5′-nucleotide phosphodiesterasesBiochemical Pharmacology, 1972
- Properties of a phosphodiesterase with high affinity for adenosine 3',5'-cyclic phosphateBiochemistry, 1971
- Papaverine - induced inhibition of phosphodiesterase activity in various mammalian tissuesLife Sciences, 1971
- A cyclic 3′,5′-AMP-stimulated protein kinase from cardiac muscleAdvances in Enzyme Regulation, 1970
- Cyclic AMPAnnual Review of Biochemistry, 1968
- Use of Liver Adenyl Cyclase for Assay of Glucagon in Human Gastro-intestinal Tract and Pancreas1Endocrinology, 1964
- Adenosine 3‘,5‘-Phosphate in Biological MaterialsJournal of Biological Chemistry, 1962
- [49a] Muscle phosphorylase bPublished by Elsevier ,1962
- STUDIES ON CARBOHYDRATE METABOLISM IN RAT LIVER SLICESJournal of Biological Chemistry, 1957